Arrowhead Research Corporation (ARWR) is a publicly traded Healthcare sector company. As of October 3, 2026, ARWR trades at $63.50 with a market cap of $9.15B and a P/E ratio of -28.67. ARWR moved -0.99% today. Year to date, ARWR is -5.31%; over the trailing twelve months it is +85.52%. Its 52-week range spans $9.57 to $95.49. Analyst consensus is strong buy with an average price target of $109.11. Rallies surfaces ARWR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ARWR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $63.50 |
| Market Cap | $9.15B |
| P/E Ratio | -28.67 |
| EPS | $-2.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $95.49 |
| 52-Week Low | $9.57 |
| Volume | 1.23M |
| Avg Volume | 0 |
| Revenue (TTM) | $669.50M |
| Net Income | $-272.13M |
| Gross Margin | 0.00% |
12 analysts cover ARWR: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $109.11.